767 — Zhong Ji Longevity Science Income Statement
0.000.00%
Last trade - 00:00- HK$218.61m
- HK$216.60m
- HK$166.18m
- 19
- 43
- 65
- 37
Annual income statement for Zhong Ji Longevity Science, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 80 | 61.1 | 89.7 | 65 | 166 |
| Cost of Revenue | |||||
| Gross Profit | 72.5 | 51.9 | 83.8 | 56.3 | 57.4 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 87.6 | 54.4 | 78.3 | 58.2 | 198 |
| Operating Profit | -7.59 | 6.75 | 11.4 | 6.76 | -31.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -9.17 | 6.96 | 9.32 | 4.75 | -33.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -10.7 | 6.2 | 0.701 | 2.52 | -34.8 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -11.5 | 6.05 | -0.904 | 2.31 | -34.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -11.5 | 6.05 | -0.904 | 2.31 | -34.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.03 | 0.004 | -0.001 | 0.002 | -0.068 |